|Podcasts|March 4, 2021
Episode 77: The Effects of AI on IP
Author(s)Elaine Quilici
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.
Advertisement
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent at the firm, talk about the increasing use of artificial intelligence in pharma and how that is affecting the realm of intellectual property.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
3
Taking Advantage of ‘Hidden Gem’ Talent Hubs
4
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
5